Skip to main content
. Author manuscript; available in PMC: 2012 Nov 22.
Published in final edited form as: J Am Coll Cardiol. 2011 Nov 22;58(22):2270–2278. doi: 10.1016/j.jacc.2011.08.041

Figure 5.

Figure 5

Figure 5a. Recovered patients have smaller cardiomyocytes at the time of VAD implantation.

Representative images (20X) of wheat germ agglutinin (green; nuclei blue) stained VAD core samples from Test Cohort Recovered and Dependent samples, with calculated cross sectional area in μM2. (n=3 per group; *p=0.01). 5b. Representative (H+E) images and measurements of cardiomyocyte diameter (μM) in the Validation Cohort Recovered and Dependent samples (n=7 per group, *p = 0.01).

HHS Vulnerability Disclosure